Skip to main content
. 2017 Jan 25;12(1):e0170673. doi: 10.1371/journal.pone.0170673

Fig 4. Distribution of donor risk index in patients undergoing liver transplantation for hepatocellular carcinoma in Era 1 (Pre-Share 35) and Era 2 (Post-Share 35).

Fig 4